VBI Vaccines
VBIV
$0.58
Share price
2.30%
Change (1 day)
-79.84%
Change (1 year)
Categories
Operating Margin for VBI Vaccines (VBIV)
Operating Margin as of May 2024 (TTM): -10,471.60%
According to VBI Vaccines 's latest financial reports and stock price the company's current Operating Margin is -10,471.60%. At the end of 2021 the company had an Operating Margin of -11,054.36%.
Operating Margin history for VBI Vaccines from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -11,054.36% | 153.7% |
| 2020 | -4,357.21% | 76.55% |
| 2019 | -2,467.94% | 30.19% |
| 2018 | -1,895.68% | -58.41% |
| 2017 | -4,557.92% | -0.03% |
| 2016 | -4,559.31% | 192.54% |
| 2015 | -1,558.53% | |
| 2004 | -166,558.65% | 909.31% |
| 2003 | -16,502.21% | 19.12% |
| 2002 | -13,853.51% | -99.9% |
| 2001 | -13,498,395.03% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | -8,391.15% | -19.87% | 🇺🇸 USA |
 Curis CRIS | -426.66% | -95.93% | 🇺🇸 USA |
 Myriad Genetics MYGN | -20.72% | -99.80% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.